Aims To investigate whether there has been further improvement in the risk of adverse outcomes in pregnancies in women with diabetes during [2008][2009][2010][2011][2012][2013][2014][2015][2016] in Bavaria, Germany.
Introduction
According to the St Vincent declaration made in 1989, the rates of adverse perinatal outcomes in pregnant women with diabetes should be reduced to numbers comparable to those in pregnant women not affected by diabetes. It has been previously shown that this objective was not achieved in women with pre-gestational diabetes in Bavaria, Germany, by 2007, although considerable improvements had been observed since 1987 [1] . Also, in later studies, diabetes in pregnancy was still reported to be associated with increased risk for adverse perinatal outcomes [2] [3] [4] [5] [6] . However, there appears to be a lack of data on recent cohorts in this context as most of these studies were based on data only recorded up until 2012. In this report we present an update of our previous analysis including data from deliveries during 2008-2016 in order to assess whether further improvement has been achieved in the management of diabetes in pregnancy. We compared perinatal outcomes in women with pre-gestational diabetes as well as gestational diabetes, with reference to outcomes in pregnant women not affected by diabetes.
identify repeat pregnancies in the same mother. We assessed associations of pre-gestational diabetes and gestational diabetes with respect to the following adverse pregnancy outcomes: preterm delivery (<37 completed weeks of gestation), stillbirth, early neonatal death (within the first seven days of life), malformations and large for gestational age neonate as defined by the upper 10% of German birthweight percentiles [7] . Additionally, associations with low 5-min Apgar score (<7) and low umbilical cord pH (<7.1) as measures of the new-born's condition [8] were explored. We calculated the rates of these adverse pregnancy outcomes in women with pre-gestational diabetes and gestational diabetes for pregnancies in 2001-2007 and 2008-2016 , respectively, derived odds ratios (ORs) with 95% confidence intervals (CIs) of each outcome for both these groups compared with the group of pregnant women not affected by diabetes as a reference, and calculated ratios of these ORs for comparing the two periods. We performed stepwise adjustment to explore potential confounding by maternal overweight (BMI> 25 kg/m²) and substandard use of antenatal care (defined as less than one antenatal visit per four weeks of gestation [9] ). Perinatal mortality (i.e. stillbirths and early neonatal deaths according to WHO definition) and malformations are the most important severe and irreversible adverse pregnancy outcomes in mothers with diabetes. We therefore aimed to identify potential high-risk subgroups by calculating multiple logistic regression models for both outcomes, with foreign country of origin, maternal smoking during pregnancy, high maternal age at delivery (≥35 years), maternal overweight, multiple delivery, hypertension, and substandard use of antenatal care as predictors for all three exposure groups (no diabetes, pre-gestational diabetes and gestational diabetes) during 2008-2016. All calculations were performed using SAS 9.4 (SAS Institute Inc., Cary, NC, USA). The program code is available at https://osf.io/edn9u/. . Multiple delivery and substandard utilization of antenatal care were also found to be significantly associated with increased risks of early mortality in this subgroup, and non-German descent with malformations ( Table 2 ). In both the pregnant women with gestational diabetes, and the pregnant women not affected by diabetes, multiple delivery and substandard use of antenatal care were observed to be the most important risk factors for early mortality, the same as foreign country of origin for malformations. There were decreasing prevalences over time with respect to maternal smoking during pregnancy (2001-2007: 7.77%; 2008-2016: 5.11%) and substandard use of antenatal care (29.90%; 26.07%) and an increasing rate of a maternal age ≥ 35 years at delivery (17.80%; 26.78%), while relatively stable rates were observed for all other potential risk factors (e.g. multiple delivery: 3.55%; 3.68%). All these temporal trends were similar across pregnant women with pregestational diabetes, gestational diabetes, or pregnant women not affected by diabetes (data not shown).
Results

Discussion
No significant improvement appears to have taken place in the management of pregnant women with pre-gestational What's new?
• This study was performed on a database which covers all deliveries in obstetric units in Bavaria, Germany, during 1987-2016 (~100 000 per year).
• The data was recorded and quality-checked uniformly over time for the purpose of benchmarking health care provision.
• There was no further improvement with respect to the number of adverse perinatal outcomes such as stillbirths in women with pre-gestational diabetes during 2008-2016 compared to 2001-2007.
• These risks were still significantly higher than in pregnancies in women without diabetes, indicating that the goals of the St Vincent declaration have not yet been achieved.
ª 2018 Diabetes UK diabetes during the last decade, while the rates of several adverse perinatal outcomes were markedly reduced in pregnant women with gestational diabetes. Interestingly, pregnant women with gestational diabetes had much more favourable perinatal outcomes than pregnant women with pre-gestational diabetes, which is in accordance with findings from another study, which suggested this may be due to the fact that pregnant women with gestational diabetes are seen more often by their obstetricians than pregnant women with pre-gestational diabetes [2] . Indeed, we observed that substandard antenatal care was less common in pregnancies affected by gestational diabetes compared with pregnancies affected by pre-gestational diabetes (e. [10] . In addition, there are an increasing number of women of child-bearing age-including a substantial proportion of migrants-for whom treatment intensity may vary [11] . We observed a higher number of women with advanced maternal age at delivery during 2008-2016 compared with 2001-2007, a factor which has been revealed to be associated with increased rates of both gestational diabetes and adverse perinatal outcomes [12] . However, advanced maternal age was a stronger predictor of perinatal mortality and malformations in pregnant women not affected by diabetes than pregnant women with diabetes in our findings, so it appears unlikely that we missed the effects of potential improvements in the management of pregnant women with diabetes solely due to temporal trends related to maternal age at delivery. This analysis is based on a very large dataset and in combination with our previous study [1] covers a period of nearly three decades. The quality of data is high as completeness of the data is monitored annually across obstetric units as an integral part of benchmarking health care provision. Our observation that the proportion of pregnancies affected by diabetes has further increased over time is consistent with the general trend of a growing diabetes prevalence in the population of Germany [13] . One limitation is that we were not able to differentiate between Type 1 diabetes and Type 2 diabetes in pregnant women with pre-gestational diabetes. With respect to gestational diabetes, it should also be noted that adoption of the new WHO diagnostic criteria in Germany in 2011, and the offer of charge-free gestational diabetes screening in 2012, may have contributed to the observed increase in diagnoses of gestational diabetes [14] . Therefore, the apparent improvement in adverse perinatal outcomes in pregnant women with gestational diabetes may partly be due to a broader inclusion of less severe cases of gestational diabetes, which may have attenuated the associated outcomes [15] . Unfortunately, we were not able to investigate this assumption in more detail because our data do not contain any laboratory measurements related to the diagnosis of diabetes such as HbA1c, or glucose values during an oral glucose-tolerance test. Another limitation was being unable to differentiate between repeated pregnancies in the same mother.
In conclusion, there appears to be room for improvement in the management of pregnant women with diabetes, in particular if diabetes already exists before the onset of pregnancy, if these women smoke, carry more than one child, or do not attend their gynecologists regularly during pregnancy.
